Miguel Stevens - Head of Global Business Development, UCB
Biography of the speaker:
Miguel Stevens joined UCB as Head of Global Business Development in October 2014. Prior to joining UCB, Miguel was Head of Business Development at ThromboGenics focusing on deal making in the ophthalmology space. Miguel previously worked in Corporate Development at Gilead Sciences where he focused on M&A and licensing in virology, oncology and cardiovascular disease. Prior to Gilead, Miguel obtained a PhD in virology from the University of Leuven. He also holds a Master degree in Pharmacy from the University of Ghent, a degree of Biotechnology from the University of Leuven, and an MBA from the Golden Gate University.